MERIDIAN BIOSCIENCE INC - COMMON STOCK (VIVO)

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / COMMON STOCK
Symbol
VIVO
Price per share
$34.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1
Total reported value
$34
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of MERIDIAN BIOSCIENCE INC - COMMON STOCK (VIVO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1 $34 $34.00 1
2025 Q2 1 $34 $34.00 1
2025 Q1 1 $34 $34.00 1
2024 Q4 1 $34 $34.00 1
2024 Q3 1 $34 $34.00 1
2024 Q2 1 $34 $34.00 1
2024 Q1 1 $34 $34.00 1
2023 Q4 1 $34 $34.00 1
2023 Q3 1 $34 $34.00 1
2023 Q2 1 $34 -$49,000 $34.00 1
2023 Q1 1,488 $49,034 -$1,372,575,925 $33.48 2
2022 Q4 41,370,222 $1,373,933,697 +$30,033,627 $33.21 217
2022 Q3 40,557,219 $1,278,907,930 -$104,120,586 $31.53 194
2022 Q2 44,298,871 $1,347,705,969 +$48,791,838 $30.42 210
2022 Q1 42,965,286 $1,115,314,779 +$58,290,313 $25.96 200
2021 Q4 41,070,855 $837,843,601 -$5,477,258 $20.40 177
2021 Q3 40,957,385 $788,141,687 -$35,735,921 $19.24 176
2021 Q2 42,978,011 $953,096,297 +$29,357,053 $22.18 188
2021 Q1 41,320,488 $1,084,354,827 +$66,974,517 $26.25 209
2020 Q4 39,181,347 $732,373,645 +$11,970,884 $18.69 187
2020 Q3 38,721,536 $657,565,054 -$18,762,570 $16.98 187
2020 Q2 39,275,812 $914,599,859 +$106,887,206 $23.29 188
2020 Q1 35,716,153 $299,983,513 -$13,977,629 $8.40 161
2019 Q4 37,103,348 $362,533,960 -$19,360,003 $9.77 164
2019 Q3 38,851,532 $368,267,600 -$1,798,801 $9.49 161
2019 Q2 38,906,285 $462,258,127 -$23,753,299 $11.88 166
2019 Q1 39,799,069 $700,861,704 +$763,492 $17.61 176
2018 Q4 39,789,934 $690,599,530 +$2,608,763 $17.36 186
2018 Q3 39,741,134 $592,164,832 +$16,117,376 $14.90 173
2018 Q2 38,677,380 $614,980,781 +$11,695,711 $15.90 175
2018 Q1 38,098,715 $541,074,394 -$7,556,336 $14.20 181
2017 Q4 38,507,216 $539,178,820 +$7,305,986 $14.00 175
2017 Q3 37,881,460 $541,682,262 +$3,960,106 $14.30 171
2017 Q2 37,569,256 $591,734,443 +$10,024,353 $15.75 168
2017 Q1 37,079,237 $511,647,521 +$47,965,203 $13.80 163
2016 Q4 37,581,873 $665,166,186 -$5,288,439 $17.70 179
2016 Q3 37,758,605 $727,354,129 -$5,869,725 $19.29 168
2016 Q2 38,060,117 $742,152,149 -$25,640,255 $19.50 177
2016 Q1 39,192,936 $808,751,210 +$12,558,546 $20.61 169
2015 Q4 39,211,310 $804,564,279 +$17,234,221 $20.52 174
2015 Q3 38,438,256 $657,279,116 -$1,951,107 $17.10 174
2015 Q2 38,430,634 $715,892,082 +$6,179,692 $18.64 168
2015 Q1 37,938,791 $723,835,478 +$5,891,919 $19.08 159
2014 Q4 37,736,224 $621,276,541 -$27,806,818 $16.46 158
2014 Q3 39,301,165 $695,240,983 -$6,126,093 $17.69 159
2014 Q2 39,235,008 $809,782,150 +$2,029,019 $20.64 161
2014 Q1 39,103,795 $852,000,981 -$20,417,946 $21.79 165